We have recently demonstrated that the novel glycoalkaloid
tomatine, derived from leaves of the wild tomato Lycopersicon pimpinellifolium, can act as a powerful adjuvant for the elicitation of
antigen-specific CD8+ T cell responses. Here, we have extended our previous investigation with the model
antigen ovalbumin to an established
malaria infection system in mice and evaluated the cellular immune response to a major preerythrocytic stage
malaria vaccine candidate
antigen when administered with
tomatine. The defined MHC H-2kd class I-binding 9-mer
peptide (
amino acids 252-260) from Plasmodium berghei circumsporozoite (CS)
protein was prepared with
tomatine to form a molecular aggregate formulation and this used to immunise BALB/c (H-2kd) mice.
Antigen-specific IFN-gamma secretion and cytotoxic T lymphocyte activity in vitro were both significantly enhanced compared to responses detected from similarly stimulated splenocytes from naive and
tomatine-saline-immunised control mice. Moreover, when challenged with P. berghei sporozoites, mice immunised with the CS 9-mer-tomatine preparation had a significantly delayed onset of erythrocytic
infection compared to controls. The data presented validate the use of
tomatine to potentiate a cellular immune response to antigenic stimulus by testing in an important biologically relevant system. Specifically, the processing of the P. berghei CS 9-mer as an exogenous
antigen and its presentation via
MHC class I molecules to CD8+ T cells led to an immune response that is an in vitro correlate of protection against preerythrocytic
malaria. This was confirmed by the protective capacity of the 9-mer-tomatine combination upon in vivo immunisation. These findings merit further work to optimise the use of
tomatine as an adjuvant in
malaria vaccine development.